Nathaniel Jenkins

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Nathaniel Jenkins sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 2 currently recruiting 4 completed upper quartile by trial count

Nathaniel Jenkins: 6 sponsored US clinical trials, 2 recruiting.

Nathaniel Jenkins sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Endothelial Dysfunction, with 2 trials.

Upper-quartile sponsor footprint

Nathaniel Jenkins sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

6 total, page 1 of 1

RECRUITING NA

ACEs, SIRT1, and Premature Vascular Aging in Humans

NCT07073352
RECRUITING NA

The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies

NCT06454344
COMPLETED NA

Citicoline Dose on Energy Drink Efficacy

NCT06890962
COMPLETED NA

Guayusa Extract on Exercise Training

NCT05820399
COMPLETED NA

Acute Effects of Organic Guayusa Extract

NCT05928195
COMPLETED NA

Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes

NCT05559372

Therapeutic Areas

Endothelial Dysfunction 2
Adverse Childhood Experiences 2
Physical Exertion 1
Desire to Exercise 1
Psychological Trauma 1
Psychosocial Stressor 1
Vascular Dilatation 1
Oxidative Stress 1
Sleep Disturbance 1
Sleep 1

What is open in the Nathaniel Jenkins pipeline

2 recruiting of 6 indexed (33% open); 4 completed (67%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Endothelial Dysfunction (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Nathaniel Jenkins: open-pipeline peers nationwide

Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Nathaniel Jenkins sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%20%40%60%80% Total trials Recruiting share Nathaniel Jenkins23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Nathaniel Jenkins sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nathaniel Jenkins sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Nathaniel Jenkins page

6 registered trials is a research-attention snapshot, not an endorsement of Nathaniel Jenkins or any single study.

  • 2 of Nathaniel Jenkins's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Endothelial Dysfunction is the condition Nathaniel Jenkins studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Endothelial Dysfunction trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Nathaniel Jenkins pipeline card: 6 registered trials from official public datasets.Report a data error.